Literature DB >> 12951129

Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonists.

Charles Q Huang1, Keith Wilcoxen, James R McCarthy, Mustapha Haddach, Thomas R Webb, Jian Gu, Yun-Feng Xie, Dimitri E Grigoriadis, Chen Chen.   

Abstract

A series of 4-substituted 8-aryl-2-methylquinolines 4 was designed and synthesized as highly potent antagonists for the human CRF(1) receptor. This series of compounds displayed parallel SAR to other bicyclic systems such as pyrazolo[1,5-a]pyrimidines, with several compounds possessing low nanomolar binding affinity. In addition to the high potency, the basicity of this 4-aminoquinoline core may offer CRF(1) antagonists with lower lipophilicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951129     DOI: 10.1016/s0960-894x(03)00684-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1.

Authors:  Supriyo Bhattacharya; Govindan Subramanian; Spencer Hall; Jianping Lin; Abdelazize Laoui; Nagarajan Vaidehi
Journal:  J Comput Aided Mol Des       Date:  2010-05-29       Impact factor: 3.686

2.  A Survey of Solvents for the Conrad-Limpach Synthesis of 4-Hydroxyquinolones.

Authors:  Jean-Cristophe Brouet; Shen Gu; Norton P Peet; John D Williams
Journal:  Synth Commun       Date:  2009-01-01       Impact factor: 2.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.